Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Pancreatic safety of incretin-based drugs--FDA and EMA assessment.

Egan AG, Blind E, Dunder K, de Graeff PA, Hummer BT, Bourcier T, Rosebraugh C.

N Engl J Med. 2014 Feb 27;370(9):794-7. doi: 10.1056/NEJMp1314078. No abstract available. Erratum in: N Engl J Med. 2014 Jun 5;370(23):2253.

2.

Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARĪ±) as a case study.

Corton JC, Cunningham ML, Hummer BT, Lau C, Meek B, Peters JM, Popp JA, Rhomberg L, Seed J, Klaunig JE.

Crit Rev Toxicol. 2014 Jan;44(1):1-49. doi: 10.3109/10408444.2013.835784. Epub 2013 Nov 4. Review.

PMID:
24180432
3.

Camptothecin induces the ubiquitin-like protein, ISG15, and enhances ISG15 conjugation in response to interferon.

Liu M, Hummer BT, Li X, Hassel BA.

J Interferon Cytokine Res. 2004 Nov;24(11):647-54.

PMID:
15684817
4.

Chromosome 18 suppresses prostate cancer metastases.

Padalecki SS, Weldon KS, Reveles XT, Buller CL, Grubbs B, Cui Y, Yin JJ, Hall DC, Hummer BT, Weissman BE, Dallas M, Guise TA, Leach RJ, Johnson-Pais TL.

Urol Oncol. 2003 Sep-Oct;21(5):366-73.

PMID:
14670546
6.

Role for p53 in gene induction by double-stranded RNA.

Hummer BT, Li XL, Hassel BA.

J Virol. 2001 Aug;75(16):7774-7.

Supplemental Content

Loading ...
Support Center